# South America DNA Synthesis Market

> South America DNA Synthesis Market Research Report: Size, Share, Trend Analysis By Applications (Gene Therapy, Synthetic Biology, Molecular Diagnostics, Vaccine Development), By Product Type (Oligonucleotides, Gene Fragments, Gene Libraries), By End Users (Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Clinical Laboratories), By Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, PCR-Based Synthesis) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 20.5%
- **2024:** $ 362.71 Million
- **2025:** $ 437.07 Million
- **2035:** $ 2,821.62 Million
- **Key Players:** Thermo Fisher Scientific (US), Illumina (US), Integrated DNA Technologies (US), Eurofins Genomics (DE), GenScript (CN), Twist Bioscience (US), Synthetic Genomics (US), Bioneer (KR), DNA Script (FR)

**Report ID:** MRFR/MED/50502-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-america-dna-synthesis-market-52260

---

## Market Summary

## **South America DNA Synthesis Market Overview**

As per MRFR analysis, the South America DNA Synthesis Market Size was estimated at 212 (USD Million) in 2023. The South America DNA Synthesis Market Industry is expected to grow from 250(USD Million) in 2024 to 750 (USD Million) by 2035. The South America DNA Synthesis Market CAGR (growth rate) is expected to be around 10.503% during the forecast period (2025 - 2035)

**Key South America DNA Synthesis Market Trends Highlighted**

In the South America DNA synthesis market, several key trends are emerging that reflect the growing importance of genetic research and biotechnology in the region. One of the principal market drivers is the rising demand for personalized medicine, which necessitates advancements in genetic research and synthesis technologies. Governments in South America are increasingly investing in biotechnology initiatives to enhance healthcare outcomes, thus propelling the DNA synthesis market forward. 

Additionally, the ongoing collaboration between academic institutions and industry players is fostering innovation, leading to the development of more efficient synthesis processes and applications.There are significant opportunities to be explored in the agricultural sector, where genetically modified organisms (GMOs) and synthetic biology can enhance crop resilience and yield. South America, being a major agricultural producer, can benefit from these advancements, addressing food security and sustainability challenges. 

Moreover, the rise of biotechnology startups across countries like Brazil and Argentina is creating a dynamic environment that encourages the exploration of novel genetic solutions in medicine and agriculture. Recently, the region has also seen a surge in investments aimed at improving laboratory infrastructure and capabilities for DNA synthesis.This includes creating more accessible and cost-effective solutions, which aligns with the trend of democratizing biotechnological advancements across South America. 

Educational programs focusing on genomics and molecular biology are also on the rise, nurturing a skilled workforce that can drive further growth in the market. Overall, the South America DNA synthesis market is characterized by a focus on innovation, collaboration, and addressing pressing regional challenges through biotechnology.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**South America DNA Synthesis Market Drivers**

**Increasing Investments in Biotechnology Research and Development**

The South America DNA synthesis market is expanding significantly as a result of rising investments in biotechnology R&D. Recognizing biotechnology's promise, governments and corporate institutions are setting aside funds to encourage innovation. For example, several advancements in DNA synthesis methods have been made possible by the approximately $10 million USD that Brazil's National Science and Technology Fund allocates each year to biotechnology initiatives. As local businesses develop in DNA synthesis techniques, this dedication to improving biotech skills is expected to strengthen the market's position in the area, making it a crucial industry in South America.

**veRising Demand for Personalized Medicine**

The rise in personalized medicine is another key driver for the South America DNA Synthesis Market Industry. Personalized medicine relies heavily on genetic information to tailor treatments to individual patients, which in turn increases the need for advanced DNA synthesis technologies. 

A recent report indicated that over 25% of South American patients are benefiting from targeted therapies that require bespoke genetic profiles. Organizations such as the Brazilian Society of Clinical Oncology are actively promoting personalized treatment approaches, which is directly driving demand for DNA synthesis services and products in the region.

**Growth in Genomic Research Initiatives**

The South America DNA Synthesis Market Industry is benefiting from a steady growth in genomic research initiatives. Countries like Brazil and Argentina are enhancing their genomic research capabilities with the establishment of various biobanks and genetic databases. 

Notably, the Brazilian Institute of Genome and Biotechnology announced a partnership for a multi-million-dollar initiative aimed at mapping the genetic diversity of plant species. This investment not only strengthens research capacity but also raises the demand for DNA synthesis technologies essential for genomic studies, making it a vital growth driver in South America.

**Increased Applications in Synthetic Biology**

The South America DNA Synthesis Market Industry is experiencing growth due to the expanded applications of synthetic biology across various sectors, including agriculture and pharmaceuticals. Companies in Argentina and Chile are actively developing genetically modified organisms to enhance crop resistance and yield. 

For example, the National Agricultural Technology Institute of Argentina has reported an increase in the use of synthetic biology to develop crops with improved traits.This trend is enhancing demand for DNA synthesis tools and services, solidifying the role of synthetic biology in fostering innovation within the South American DNA Synthesis Market Industry.

**South America DNA Synthesis Market Segment Insights**

**DNA Synthesis Market Application Insights**

The South America DNA Synthesis Market, particularly in the Application segment, is experiencing significant growth fueled by advancements across various fields such as Gene Therapy, Synthetic Biology, Molecular Diagnostics, and Vaccine Development. Gene Therapy plays a crucial role in treating genetic disorders, driving demand for sophisticated DNA synthesis techniques that aim to enhance precision in treatment. This Application remains a major focus due to its potential for groundbreaking therapies, addressing unmet medical needs in the region.

Synthetic Biology, another vital area within the Application segment, revolutionizes the way organisms are engineered, presenting vast opportunities for innovations in agriculture and biofuels that are highly relevant to South America's rich biodiversity. Moreover, Molecular Diagnostics stands out as a critical tool for disease detection and monitoring, particularly in the wake of increased health concerns, allowing for timely intervention and personalized medicine strategies. 

It is significant that this application leverages cutting-edge DNA synthesis technology to enhance diagnostic accuracy and speed.Lastly, Vaccine Development has received considerable attention, especially following the global health crises that highlighted the urgency for rapid and effective vaccine solutions. The ongoing investments in vaccine research and the development of new platforms signify the importance of this Application, emphasizing a united effort to improve public health and preparedness in South America. 

Collectively, these segments underscore a favorable environment for technological advancements and healthcare enhancements driven by the South America DNA Synthesis Market, signaling robust growth opportunities supported by regional biodiversity and an expanding scientific community.As these applications evolve, they not only contribute significantly to the South American economy but also highlight the region's commitment to innovation and healthcare improvement.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**DNA Synthesis Market Product Type Insights**

The South America DNA Synthesis Market demonstrates a diverse range of Product Types, prominently featuring Oligonucleotides, Gene Fragments, and Gene Libraries. Oligonucleotides are critical in various applications, including Research and Development, diagnostics, and therapeutic strategies, thereby contributing to remarkable growth in the biotechnology sector. Gene Fragments play a significant role as building blocks in genetic research, facilitating advancements in synthetic biology and personalized medicine. 

Meanwhile, Gene Libraries serve as valuable resources for researchers, enabling comprehensive genetic exploration and increasing the efficiency of gene discovery processes.The rising demand for precision medicine and next-generation sequencing technologies underscores the importance of these product types. In South America, the increasing emphasis on genomic research, coupled with advancements in biotechnology, establishes a dynamic environment where these product types can thrive. 

This market is further supported by favorable government initiatives aimed at enhancing research capabilities and fostering innovation in the life sciences industry, creating promising opportunities for growth and collaboration.

**DNA Synthesis Market End User Insights**

The End User segment of the South America DNA Synthesis Market comprises Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories. Academic Research Institutions are crucial in driving innovation and discovery, playing a pivotal role in advancing genetic research and education. Pharmaceutical Companies leverage DNA synthesis for drug development and personalized medicine, significantly enhancing therapeutic options and improving patient outcomes. Biotechnology Companies utilize DNA synthesis to create novel products and solutions that cater to various industries, emphasizing the importance of synthetic biology in addressing global challenges.

Clinical Laboratories rely on advanced DNA synthesis techniques for diagnostic testing and genomic analysis, ensuring high accuracy in medical assessments. These sectors collectively contribute to the market's expansion, driven by increasing demand for genetic research, advancements in therapeutics, and rising investments in biotechnology. The growing focus on Research and Development in South America, supported by government initiatives and funding, further strengthens the potential of these end users, making them fundamental to the overall growth and evolution of the South America DNA Synthesis Market.

**DNA Synthesis Market Technology Insights**

The South America DNA Synthesis Market is experiencing significant developments in the Technology segment, which encompasses various synthesis methods essential for genetic engineering and molecular biology applications. Within this framework, Solid-Phase Synthesis is notable for its efficiency in constructing oligonucleotides, making it a preferred choice for numerous researchers focused on high-throughput applications. Liquid-Phase Synthesis, while less common, finds its relevance in specific applications where flexibility and adaptability are required.Furthermore, PCR-Based Synthesis is a pivotal technique widely used in diagnostics and research, allowing for the amplification of specific DNA sequences. 

As the demand for personalized medicine and genetic testing rises in South America, these methods are becoming increasingly important. The insights from South America DNA Synthesis Market data indicate substantial growth driven by advancements in technology, a surge in Research and Development activities, and rising investments in pharmaceutical and biotechnology industries. Overall, the blending of these technologies is crucial for the market's dynamics, providing essential tools for innovation and research across various sectors in the region.

**South America DNA Synthesis Market Key Players and Competitive Insights**

The competitive landscape of the South America DNA Synthesis Market is characterized by a dynamic interplay of various players striving to capitalize on the growing demand for synthetic DNA across multiple applications such as biotechnology, pharmaceuticals, and agriculture. As research and development activities expand across universities and private research institutions, the market has seen an increase in investment, which, in turn, has fostered innovation and product development. Key players are focusing on enhancing their service offerings to address the specific needs of the regional market, including the affordability and accessibility of DNA synthesis technologies. 

The landscape is also shaped by collaborations, partnerships, and investment in infrastructure that aims to support scientific advancements and meet the unique challenges within the South American context.Agilent Technologies has established a strong foothold in the South America DNA Synthesis Market through its innovative offerings and extensive expertise in biotechnology. The company is recognized for its advanced technologies that facilitate efficient DNA synthesis processes, which are crucial for various applications in research laboratories and industrial setups across the region. 

Agilent Technologies leverages its robust distribution network and sales force to maintain a significant presence in key markets such as Brazil and Argentina. Its strengths lie in the reliability of its products, coupled with strong customer support and a commitment to quality, which have cemented its reputation as a leading provider in DNA synthesis solutions within South America.

This operational efficiency enables Agilent Technologies to adapt swiftly to market demands and maintain a competitive edge.Thermo Fisher Scientific is another major player in the South America DNA Synthesis Market, renowned for its comprehensive portfolio of products and services that cater to a range of scientific needs. 

The company offers a variety of synthesis solutions, including oligonucleotides and gene constructs that are essential for genetic research and development. With a strong market presence, Thermo Fisher Scientific focuses on enhancing its service capabilities and expanding its product lines to meet the specific demands of South American researchers and institutions. Key strengths of the company include its technological advancements, which ensure high-quality synthesis, and its commitment to customer service, making it a preferred choice among scientists. 

Thermo Fisher Scientific has also engaged in strategic mergers and acquisitions aimed at bolstering its market position and enhancing its research capabilities in the region, thus ensuring a sustained competitive advantage in the rapidly evolving DNA synthesis landscape.

**Key Companies in the South America DNA Synthesis Market Include**

**South America DNA Synthesis Market Industry Developments**

The South America DNA Synthesis Market has seen notable developments recently, particularly with companies like Agilent Technologies and Thermo Fisher Scientific expanding their operational capabilities in the region. In September 2023, Twist Bioscience announced a significant investment in enhancing its manufacturing facility in Brazil, aimed at increasing its production capacity for synthetic DNA, thus catering to the growing demand in the biotechnology sector. Alongside this, Qiagen and Genomatica have been collaborating on projects focused on sustainable DNA synthesis processes, reflecting the increasing importance of environmental considerations in biotechnology. 

Furthermore, in August 2023, Bioneer was reported to have secured a strategic partnership with local universities to foster Research and Development initiatives, enhancing local talent and innovation. In terms of mergers and acquisitions, ThermoGenesis Holdings was noted to have completed an acquisition of a Brazilian biotechnology firm in July 2023, aligning with their strategy to strengthen their presence in the South American DNA synthesis landscape. The overall market valuation is expected to increase significantly due to these developments, contributing to regional advancements and the rapid growth of synthetic biology applications across various sectors, including healthcare and agriculture.

**South America DNA Synthesis Market Segmentation Insights**

## Market Drivers

### Growing Biopharmaceutical Sector

The biopharmaceutical sector in South America is experiencing substantial growth, which is significantly impacting the DNA synthesis market. With an increasing number of biopharmaceutical companies focusing on developing novel therapies, the demand for custom DNA synthesis is on the rise. In 2025, the biopharmaceutical market in South America is expected to reach approximately $50 billion, indicating a robust growth trajectory. This surge is driven by the need for personalized medicine and targeted therapies, which rely heavily on synthetic DNA. Consequently, the DNA synthesis market is likely to benefit from partnerships and collaborations between biopharmaceutical firms and DNA synthesis providers, enhancing innovation and product offerings.

### Rising Awareness of Genetic Research

The growing awareness of genetic research among the South American population is influencing the DNA synthesis market. As educational institutions and research organizations emphasize the importance of genetics in health and agriculture, there is an increasing interest in synthetic biology applications. This heightened awareness is likely to lead to a greater demand for DNA synthesis services, as researchers seek to explore genetic modifications and innovations. Furthermore, public interest in genetic testing and personalized medicine is expected to drive market growth. The DNA synthesis market may see a rise in collaborations between academic institutions and commercial entities, fostering a culture of innovation and research in the region.

### Emerging Startups in Synthetic Biology

The emergence of startups focused on synthetic biology in South America is a dynamic driver for the DNA synthesis market. These startups are often agile and innovative, bringing fresh ideas and technologies to the market. Many are concentrating on developing cost-effective and efficient DNA synthesis solutions, which could disrupt traditional methods. The startup ecosystem is thriving, with an estimated 150 new companies entering the biotechnology space in the past year alone. This influx of new players is likely to stimulate competition and drive advancements in DNA synthesis technologies. As these startups collaborate with established firms and research institutions, the DNA synthesis market is poised for significant growth and transformation.

### Technological Advancements in DNA Synthesis

The rapid evolution of technology in the DNA synthesis market is a pivotal driver in South America. Innovations such as next-generation sequencing and CRISPR technology are enhancing the efficiency and accuracy of DNA synthesis processes. These advancements are likely to reduce costs, making synthetic biology more accessible to researchers and companies. As a result, the market is projected to grow at a CAGR of approximately 15% over the next five years. This growth is fueled by the increasing application of synthetic DNA in pharmaceuticals, agriculture, and biotechnology, which are critical sectors in South America. The integration of automation and artificial intelligence in DNA synthesis workflows further streamlines operations, potentially increasing throughput and reducing turnaround times.

### Increased Funding for Biotechnology Initiatives

In South America, there is a notable increase in funding directed towards biotechnology initiatives, which serves as a significant driver for the DNA synthesis market. Governments and private investors are recognizing the potential of biotechnology to address health and agricultural challenges. For instance, funding for biotechnology research has increased by over 20% in recent years, facilitating advancements in DNA synthesis technologies. This influx of capital is likely to support the development of new applications in synthetic biology, including gene editing and synthetic vaccines. As a result, the DNA synthesis market is expected to expand, driven by the growing number of projects and research initiatives aimed at leveraging synthetic DNA for innovative solutions.

## Future Outlook

The [DNA synthesis Market](https://www.marketresearchfuture.com/reports/dna-synthesis-market-20306) is poised for robust growth at 20.5% CAGR from 2025 to 2035, driven by advancements in biotechnology, increased demand for synthetic biology, and rising applications in personalized medicine.

**New opportunities:**

- Development of customized DNA synthesis platforms for research institutions. Expansion of contract manufacturing services for biotech startups. Integration of AI-driven analytics for optimized synthesis processes.

By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in biotechnological advancements.

## Segment Insights

### By Application: Gene Therapy (Largest) vs. Vaccine Development (Fastest-Growing)

The market share distribution in the Application segment reveals Gene Therapy as the largest contributor, leveraging its established foothold in therapeutic solutions. Meanwhile, Vaccine Development is gaining momentum, reflecting increasing investments in health security and innovation driven by recent global health crises. This dynamic interplay highlights the diverse applications driving growth in the sector. In terms of growth trends, Vaccine Development is expected to witness the fastest expansion due to heightened demand for rapid response capabilities to emerging infectious diseases. Additionally, Gene Therapy continues to evolve, supported by a growing understanding of genomics and advancements in delivery mechanisms. These factors contribute to sustained interest and investment across the segment, making it a focal point for market participants.

Gene Therapy (Dominant) vs. Synthetic Biology (Emerging)

Gene Therapy stands out as a dominant force within the Application segment, characterized by its unprecedented potential in treating genetic disorders through personalized medicine approaches. This segment is heavily backed by regulatory advancements and increasing clinical trials showcasing efficacy. On the other hand, Synthetic Biology is emerging with significant innovation, driven by advancements in genetic engineering and computational biology. As researchers strive to create synthetic organisms for varied applications, especially in biotechnology and environmental management, this segment is gaining traction. Both segments present unique opportunities, with Gene Therapy focusing on transformative therapeutic solutions while Synthetic Biology paves the way for future applications across industries.

### By Product Type: Oligonucleotides (Largest) vs. Gene Fragments (Fastest-Growing)

In the South America dna synthesis market, the product type segment reveals a dynamic distribution of market share. Oligonucleotides dominate the market, significantly surpassing gene fragments and gene libraries in terms of demand and overall usage. The preference for oligonucleotides is attributed to their extensive applications in diagnostic and therapeutic realms, solidifying their leading position. Conversely, gene fragments hold a smaller but rapidly expanding stake in the market, driven by the escalating need for precise genetic modifications and advancements in synthetic biology. Growth trends within this segment indicate an upward trajectory, particularly for gene fragments, which are recognized as the fastest-growing category. This growth is fueled by increasing investment in genetic engineering and biotechnological research. As newer technologies enhance the efficiency and accessibility of gene synthesis processes, these segments are poised for substantial expansion, reflecting the broader trends in the life sciences sector and innovation in DNA-based applications.

Oligonucleotides: Dominant vs. Gene Fragments: Emerging

Oligonucleotides represent the dominant force in the South America dna synthesis market due to their versatility and pivotal role in numerous applications such as PCR, gene editing, and therapeutic development. Their ability to be synthesized quickly and tailored for specific purposes makes them indispensable in research and clinical settings. On the other hand, gene fragments are an emerging segment, gaining traction for their essential role in constructing larger genetic constructs and enabling advanced gene therapies. As research initiatives expand, the demand for gene fragments is expected to rise, with innovation in synthesis techniques helping to enhance their market appeal, thus paving the way for significant growth in this area.

### By End User: Pharmaceutical Companies (Largest) vs. Academic Research Institutions (Fastest-Growing)

In the South America dna synthesis market, Pharmaceutical Companies hold the largest market share, driven by their significant investments in drug development and genetic research. The strong demand for personalized medicine and advancements in genomics are key factors propelling this segment's dominance. Academic Research Institutions follow closely, showing a rapid increase in adoption due to growing research initiatives and funding for genetic studies in the region. Growth trends indicate a robust future for Academic Research Institutions, making them the fastest-growing end user in the market. This surge is largely attributed to increased collaboration between academic entities and commercial organizations, enhancing research capabilities. Additionally, the rise in government and private funding for biological research supports the expansion of capabilities among these institutions, fostering innovation in dna synthesis applications.

Pharmaceutical Companies (Dominant) vs. Academic Research Institutions (Emerging)

Pharmaceutical Companies dominate the end user segment due to their substantial resources and ongoing research and development activities that utilize dna synthesis for drug discovery. Their established market presence allows them to leverage advanced genetic engineering techniques in therapeutic applications. In contrast, Academic Research Institutions represent the emerging segment, increasingly focusing on collaborative efforts with industry players to push the boundaries of genetic research. Their agility in adapting to new technologies and methodologies contributes to a surge in innovative projects, positioning them as a crucial player in integrating dna synthesis into various scientific explorations.

### By Technology: Solid-Phase Synthesis (Largest) vs. PCR-Based Synthesis (Fastest-Growing)

In the South America dna synthesis market, Solid-Phase Synthesis holds the largest market share due to its established method of oligonucleotide production, favored for its efficiency and high yield. Meanwhile, Liquid-Phase Synthesis is also significant but continues to face competition from more advanced techniques. PCR-Based Synthesis is rapidly gaining traction as it offers significant advantages in speed and flexibility, appealing to the growing demand for rapid genetic analysis. Growth trends in this segment are driven by increasing applications of DNA synthesis in various fields such as healthcare, biotechnology, and agriculture. The rising adoption of personalized medicine is propelling PCR-Based Synthesis, making it a key player for future growth. Moreover, advancements in synthesis technologies and increased investment in genetic research are also contributing to the expansion of this market segment.

Technology: Solid-Phase Synthesis (Dominant) vs. PCR-Based Synthesis (Emerging)

Solid-Phase Synthesis is recognized for its stability and capacity to generate high-quality oligonucleotides, which makes it a trusted choice in various applications like drug development and diagnostics. Its established market presence and reliability render it the dominant force in the South America dna synthesis market. Conversely, PCR-Based Synthesis, marked as an emerging method, is gaining ground due to its speed and adaptability, catering to the needs of fast-paced genetic testing environments. This method's ability to rapidly amplify DNA segments makes it essential for laboratories that require quick results and supports burgeoning fields such as molecular biology and genetic engineering.

## Regional Market Share Analysis

### Brazil : Brazil's Dominance in Biotechnology

Brazil holds a commanding market share of 41.5% in the South American DNA synthesis market, valued at $150.0 million. Key growth drivers include a robust biotechnology sector, increasing investments in genomics, and a rising demand for personalized medicine. Government initiatives, such as the National Biotechnology Policy, support research and development, while improving infrastructure enhances industrial capabilities, fostering a conducive environment for market expansion.

### Mexico : Mexico's Growing Biotech Landscape

Mexico accounts for 22.5% of the South American DNA synthesis market, with a value of $80.0 million. The growth is driven by increasing research activities in universities and private sectors, alongside government support for biotech startups. Demand for DNA synthesis is rising in pharmaceuticals and agriculture, with regulatory frameworks evolving to facilitate innovation and investment in biotechnology.

### Argentina : Argentina's Biotech Advancements

Argentina holds a market share of 20.5%, valued at $70.0 million in the DNA synthesis sector. The growth is fueled by a strong academic research base and collaborations with international biotech firms. Government policies promoting scientific research and innovation are enhancing the market landscape. The demand for DNA synthesis is particularly strong in agriculture and healthcare, reflecting local consumption patterns.

### Rest of South America : Untapped Markets in South America

The Rest of South America represents a market share of 17.5%, valued at $62.71 million. This sub-region includes countries like Chile, Colombia, and Peru, where the DNA synthesis market is gradually developing. Growth drivers include increasing investments in healthcare and agriculture, alongside supportive government policies. The demand for DNA synthesis is emerging in various sectors, including environmental and agricultural biotechnology.

## Competitive Benchmarking

The dna synthesis market in South America is characterized by a dynamic competitive landscape, driven by advancements in biotechnology and increasing demand for synthetic biology applications. Key players such as Thermo Fisher Scientific (US), Illumina (US), and GenScript (CN) are strategically positioned to leverage innovation and regional expansion. Thermo Fisher Scientific (US) focuses on enhancing its product portfolio through continuous innovation, while Illumina (US) emphasizes partnerships to expand its market reach. GenScript (CN) is actively pursuing mergers and acquisitions to bolster its capabilities, collectively shaping a competitive environment that is increasingly collaborative and innovation-driven.The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in a region where logistical challenges can impact operational efficiency. The collective influence of these major players fosters a competitive atmosphere that encourages innovation and responsiveness to market demands.

In October  Thermo Fisher Scientific (US) announced the launch of a new line of custom oligonucleotides aimed at enhancing gene editing applications. This strategic move is significant as it not only expands their product offerings but also positions them to capture a larger share of the growing gene therapy market, which is expected to see substantial growth in the coming years. The introduction of these products reflects a commitment to innovation and meeting the evolving needs of researchers in the region.

In September  Illumina (US) entered into a strategic partnership with a leading South American research institution to develop next-generation sequencing technologies tailored for local applications. This collaboration is indicative of Illumina's strategy to deepen its market penetration and foster innovation through localized research efforts. By aligning with regional experts, Illumina enhances its credibility and adaptability in addressing specific market needs.

In August  GenScript (CN) completed the acquisition of a South American biotech firm specializing in CRISPR technology. This acquisition is pivotal as it not only expands GenScript's technological capabilities but also enhances its competitive positioning in the rapidly evolving field of gene editing. The integration of this technology is likely to accelerate product development timelines and improve service offerings in the region.

As of November  current trends in the dna synthesis market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into research and development processes. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and innovative solutions that meet the specific needs of the market.

## Recent News & Developments

The South America DNA Synthesis Market has seen notable developments recently, particularly with companies like Agilent Technologies and Thermo Fisher Scientific expanding their operational capabilities in the region. In September 2023, Twist Bioscience announced a significant investment in enhancing its manufacturing facility in Brazil, aimed at increasing its production capacity for synthetic DNA, thus catering to the growing demand in the biotechnology sector. Alongside this, Qiagen and Genomatica have been collaborating on projects focused on sustainable DNA synthesis processes, reflecting the increasing importance of environmental considerations in biotechnology. 

Furthermore, in August 2023, Bioneer was reported to have secured a strategic partnership with local universities to foster Research and Development initiatives, enhancing local talent and innovation. In terms of mergers and acquisitions, ThermoGenesis Holdings was noted to have completed an acquisition of a Brazilian biotechnology firm in July 2023, aligning with their strategy to strengthen their presence in the South American DNA synthesis landscape. The overall market valuation is expected to increase significantly due to these developments, contributing to regional advancements and the rapid growth of synthetic biology applications across various sectors, including healthcare and agriculture.

## Report Scope

| MARKET SIZE 2024 | 362.71(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 437.07(USD Million) |
| MARKET SIZE 2035 | 2821.62(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 20.5% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Thermo Fisher Scientific (US), Illumina (US), Integrated DNA Technologies (US), Eurofins Genomics (DE), GenScript (CN), Twist Bioscience (US), Synthetic Genomics (US), Bioneer (KR), DNA Script (FR) |
| Segments Covered | Application, Product Type, End User, Technology |
| Key Market Opportunities | Emerging biotechnologies drive demand for customized solutions in the dna synthesis market. |
| Key Market Dynamics | Growing demand for personalized medicine drives innovation and competition in the DNA synthesis market. |
| Countries Covered | Brazil, Mexico, Argentina, Rest of South America |

## Frequently Asked Questions

**Q: What is the current valuation of the DNA synthesis market in South America?**
A: The overall market valuation was $362.71 Million in 2024.

**Q: What is the projected market size for DNA synthesis in South America by 2035?**
A: The projected valuation for 2035 is $2821.62 Million.

**Q: What is the expected CAGR for the DNA synthesis market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during this period is 20.5%.

**Q: Which application segments are driving growth in the DNA synthesis market?**
A: Key application segments include Gene Therapy, Synthetic Biology, Molecular Diagnostics, and Vaccine Development.

**Q: What were the revenue figures for the Vaccine Development segment in 2024?**
A: The Vaccine Development segment generated $132.71 Million in 2024.

**Q: Which product types are most prominent in the DNA synthesis market?**
A: Prominent product types include Oligonucleotides, Gene Fragments, and Gene Libraries.

**Q: What was the revenue for Gene Libraries in 2024?**
A: The Gene Libraries segment reported $162.97 Million in 2024.

**Q: Who are the key players in the South America DNA synthesis market?**
A: Key players include Thermo Fisher Scientific, Illumina, Integrated DNA Technologies, and others.

**Q: What end-user segments are contributing to the market growth?**
A: End-user segments include Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories.

**Q: What was the revenue for Pharmaceutical Companies in 2024?**
A: Pharmaceutical Companies generated $108.81 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-dna-synthesis-market-52260*